Republicans are eyeing an opportunity to enact a bipartisan health package by the end of the year, but Democrats aren’t exactly in a deal-making mood.
With the dust barely settled after enacting their party-line domestic policy megabill, GOP lawmakers on the Senate Finance, House Ways and Means and House Energy and Commerce committees are hoping they’ll have another shot this year at making policy changes to drug pricing long sought by both parties.
It will be a litmus test for whether lawmakers can come together during President Donald Trump’s polarizing second term — and in the aftermath of the enactment of the Republican megabill, which…
Read the full article at POLITICO.COM
